{"schema_version":"1.0","hypothesis_id":39019,"triple":{"drug":"bimekizumab","drug_canonical":"bimekizumab","mediator":"IL-17A","mediator_canonical":"il-17a","outcome":"islet β-cell apoptosis","outcome_canonical":"islet β-cell apoptosis"},"domain":{"domain":"cross_domain","source":"rheumatoid_arthritis","target":"pancreatic_cancer"},"provenance_completeness":"partial_backfill","completeness_notes":"Backfilled retroactively from DB state on 2026-05-13. The pipeline_run this row references was created by the backfill script, not by the actual generation orchestrator. Source papers, claims, scoring, and embedding config are recovered; generation-time metadata (exact git commit at gen time, host, exact command) is not recoverable.","source_papers":[{"doi":"10.1177/1759720x241293944","pmid":"39620046","year":2024,"roles":["drug_mediator"],"title":"Impact of bimekizumab and certolizumab pegol on efficacy, safety and osteoblastic activity in radiographic axial spondyloarthritis: results from a phase IIa, multicentre, randomised, double-blind, exploratory study with PET-CT imaging","journal":"Ther Adv Musculoskelet Dis","work_id":298744,"publication_date":"2024-01-01"},{"doi":"10.1007/s40744-024-00708-8","pmid":"39215949","year":2024,"roles":["drug_mediator"],"title":"Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies","journal":"Rheumatol Ther","work_id":288014,"publication_date":"2024-08-31"},{"doi":"10.2147/ppa.s427809","pmid":"37808274","year":2023,"roles":["drug_mediator"],"title":"Safe and Effective Subcutaneous Self-Injection of Bimekizumab with Safety Syringe and Auto-Injector Devices: Results from a Multicenter, Randomized, Open-Label Study in Patients with Psoriatic Arthritis","journal":"Patient Prefer Adherence","work_id":298918,"publication_date":"2023-10-01"},{"doi":"10.1016/s0140-6736(22)02302-9","pmid":"36493791","year":2022,"roles":["drug_mediator"],"title":"Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)","journal":"Lancet","work_id":286081,"publication_date":"2022-12-05"},{"doi":null,"pmid":"33294254","year":2020,"roles":["mediator_outcome"],"title":"IL-17 in pancreatic disease: pathogenesis and pharmacotherapy.","journal":"Am J Cancer Res","work_id":171028,"publication_date":"2020-01-01"},{"doi":"10.1136/annrheumdis-2018-214943","pmid":"31177099","year":2019,"roles":["drug_mediator"],"title":"Efficacy and safety of bimekizumab as add-on therapy for rheumatoid arthritis in patients with inadequate response to certolizumab pegol: a proof-of-concept study","journal":"Ann Rheum Dis","work_id":288561,"publication_date":"2019-06-08"}],"source_paper_count":6,"extracted_claims":[{"side":"drug_mediator","object":"IL-17A","context":"in patients with psoriatic arthritis","subject":"bimekizumab","work_id":286081,"claim_id":206413,"polarity":"positive","predicate":"inhibits","confidence":0.95,"extraction_run_id":29},{"side":"drug_mediator","object":"IL-17A","context":"in patients with psoriatic arthritis","subject":"Bimekizumab","work_id":288014,"claim_id":211462,"polarity":"positive","predicate":"inhibits","confidence":0.95,"extraction_run_id":29},{"side":"drug_mediator","object":"IL-17A","context":"rheumatoid arthritis patients","subject":"bimekizumab","work_id":288561,"claim_id":213900,"polarity":"positive","predicate":"inhibits","confidence":0.9,"extraction_run_id":29},{"side":"drug_mediator","object":"IL-17A","context":"in patients with radiographic axial spondyloarthritis","subject":"bimekizumab","work_id":298744,"claim_id":250889,"polarity":"positive","predicate":"inhibits","confidence":0.95,"extraction_run_id":29},{"side":"drug_mediator","object":"IL-17A","context":"in patients with psoriatic arthritis","subject":"bimekizumab","work_id":298918,"claim_id":251450,"polarity":"positive","predicate":"inhibits","confidence":0.95,"extraction_run_id":29},{"side":"mediator_outcome","object":"islet β-cell apoptosis","context":"in islet inflammation","subject":"IL-17A","work_id":171028,"claim_id":121074,"polarity":"positive","predicate":"causes","confidence":0.85,"extraction_run_id":23}],"extracted_claim_count":6,"extraction":{"model":"deepseek-v4-flash","model_source":"configured","prompt_version":"v1_2026_05_07","run_ids":[23,29]},"bridge":{"a_to_b_predicate":"inhibits","b_to_c_predicate":"causes","a_to_b_evidence_count":5,"b_to_c_evidence_count":1,"edge_support_log_ab":1.791759469228055,"edge_support_log_bc":0.6931471805599453,"novelty_factor":1.0,"direct_a_to_c_count":0},"embedding":{"model":"bge-m3","dim":1024,"max_length":8192,"similarity_scores":{}},"scoring":{"method":"swanson_abc_log_evidence_with_novelty_penalty","formula":"score = min((log(ab+1) + log(bc+1)) * novelty / 10, 1.0); novelty = 1.0 if direct==0 else 0.7 / (direct+1)","score_raw":0.24849066497880004,"score":0.24849066497880004,"quality_tier":"mid","quality_reason":null},"pipeline_run":{"id":4,"run_uuid":"eb8b7730-d92e-4cd5-95dd-95f6c5d62cc2","command":"scripts/backfill_provenance_v2.py:v2_2026_05_12","status":"completed","git_commit":"9996ffaa56e9b7cd5f677bd8203624c2c18aa000","host":"MacBook-Pro-Daniel96.local","started_at":"2026-05-12T21:35:53.363326+00:00","ended_at":"2026-05-12T21:43:41.903387+00:00","notes":"Retroactive provenance backfill on 2026-05-13 for snapshot v2_2026_05_12. Synthetic pipeline_runs row — original generation run records are lost (pre-date provenance schema). All recoverable fields populated from current DB state (claims, works, repurposing_hypotheses); pipeline_run record is synthetic, hence completeness='partial_backfill'.\nBackfilled 1,618 provenance rows. Source papers: avg=3.73, zero=0. Claims matched: avg=4.09, zero=0.\nRefreshed 1,618 provenance rows. Source papers: avg=3.73, zero=0. Claims matched: avg=4.09, zero=0.\nRefreshed 1,618 provenance rows. Source papers: avg=3.73, zero=0. Claims matched: avg=4.09, zero=0.","domains":["als","alzheimer","depression","epilepsy","glioblastoma","inflammatory_bowel_disease","multiple_sclerosis","pancreatic_cancer","rheumatoid_arthritis","type_2_diabetes"]},"generated_at":"2026-05-12T21:43:40.945575+00:00"}